CD133, Selectively Targeting the Root of Cancer

Toxins - Switzerland
doi 10.3390/toxins8060165
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Selectively Targeting Estrogen Receptors for Cancer Treatment

Advanced Drug Delivery Reviews
Pharmaceutical Science
2010English

Characterization of Transgenic Mouse Lines for Selectively Targeting Glial Cells in Dorsal Root Ganglia

2020English

Selectively Targeting Prostate Cancer With Antiandrogen Equipped Histone Deacetylase Inhibitors

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2013English

Characterization of the Conversion Between CD133+and CD133-cells in Colon Cancer SW620 Cell Line

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2012English

Delivery of Anti-miRNA for Triple Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting to Stem Cell Marker CD133

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Growth Kinetics of CD133-positive Prostate Cancer Cells

Prostate
OncologyUrology
2012English

Prognostic Value of CD133 and SOX2 in Advanced Cancer

Journal of Oncology
Oncology
2019English

Targeting the Duality of Cancer

npj Precision Oncology
2017English

Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy